Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells

Experimental Hematology

Volumn 35, Issue 10, 2007, Pages 1538-1549

  van Gosliga, Djoke ^a   Schepers, Hein ^a   Rizo, Aleksandra ^a   van der Kolk, Dorina ^a   Vellenga, Edo ^a   Schuringa, Jan Jacob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOX A9; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CD34 SELECTION; CELL DIFFERENTIATION; CELL REGENERATION; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; STROMA CELL;

ANTIGENS, CD34; BONE MARROW CELLS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, LEUKEMIC; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; STROMAL CELLS; TIME FACTORS; TUMOR STEM CELL ASSAY; TUMOR STEM CELLS;

EID: 34548688894     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.07.001     Document Type: Article

References (39)

1. Lapidot T., Sirard C., Vormoor J., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
2. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med 3 (1997) 730-737
3. Kollet O., Peled A., Byk T., et al. Beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95 (2000) 3102-3105
4. Warner J.K., Wang J.C., Hope K.J., Jin L., and Dick J.E. Concepts of human leukemic development. Oncogene 23 (2004) 7164-7177
5. Wang J.C., and Dick J.E. Cancer stem cells: lessons from leukemia. Trends Cell Biol 15 (2005) 494-501
6. Hope K.J., Jin L., and Dick J.E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5 (2004) 738-743
7. Moore M.A., Williams N., and Metcalf D. In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells. J Natl Cancer Inst 50 (1973) 603-623
8. Minden M.D., Buick R.N., and McCulloch E.A. Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood 54 (1979) 186-195
9. Vellenga E., Young D.C., Wagner K., Wiper D., Ostapovicz D., and Griffin J.D. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 69 (1987) 1771-1776
10. McCulloch E.A. Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982). Blood 62 (1983) 1-13
11. Ailles L.E., Gerhard B., and Hogge D.E. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood 90 (1997) 2555-2564
12. Sutherland H.J., Blair A., and Zapf R.W. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood 87 (1996) 4754-4761
13. Jordan C.T., Upchurch D., Szilvassy S.J., et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14 (2000) 1777-1784
14. Taussig D.C., Pearce D.J., Simpson C., et al. Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 106 (2005) 4086-4092
15. Blair A., Hogge D.E., Ailles L.E., Lansdorp P.M., and Sutherland H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89 (1997) 3104-3112
16. Blair A., Hogge D.E., and Sutherland H.J. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-. Blood 92 (1998) 4325-4335
17. Blair A., and Sutherland H.J. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp Hematol 28 (2000) 660-671
18. Pearce D.J., Taussig D., Zibara K., et al. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood 107 (2006) 1166-1173
19. Kanai M., Hirayama F., Yamaguchi M., et al. Stromal cell-dependent ex vivo expansion of human cord blood progenitors and augmentation of transplantable stem cell activity. Bone Marrow Transplant 26 (2000) 837-844
20. Kusadasi N., van Soest P.L., Mayen A.E., Koevoet J.L., and Ploemacher R.E. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood. Leukemia 14 (2000) 1944-1953
21. Piacibello W., Sanavio F., Severino A., et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 93 (1999) 3736-3749
22. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
23. Chung K.Y., Morrone G., Schuringa J.J., Wong B., Dorn D.C., and Moore M.A. Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis. Blood 105 (2005) 77-84
24. Falini B., Mecucci C., Tiacci E., et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352 (2005) 254-266
25. Ailles L.E., Gerhard B., Kawagoe H., and Hogge D.E. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood 94 (1999) 1761-1772
26. Vellenga E., Ostapovicz D., O'Rourke B., and Griffin J.D. Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1 (1987) 584-589
27. Mizuki M., Fenski R., Halfter H., et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood 96 (2000) 3907-3914
28. Spiekermann K., Bagrintseva K., Schwab R., Schmieja K., and Hiddemann W. Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells. Clin Cancer Res 9 (2003) 2140-2150
29. Birkenkamp K.U., Geugien M., Lemmink H.H., Kruijer W., and Vellenga E. Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts. Leukemia 15 (2001) 1923-1931
30. Schuringa J.J., Chung K.Y., Morrone G., and Moore M.A. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation. J Exp Med 200 (2004) 623-635
31. Rombouts W.J., Blokland I., Lowenberg B., and Ploemacher R.E. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene. Leukemia 14 (2000) 675-683
32. Mulloy J.C., Cammenga J., Berguido F.J., et al. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood 102 (2003) 4369-4376
33. Yuan Y., Zhou L., Miyamoto T., et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci U S A 98 (2001) 10398-10403
34. Rhoades K.L., Hetherington C.J., Harakawa N., et al. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood 96 (2000) 2108-2115
35. Schessl C., Rawat V.P., Cusan M., et al. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest 115 (2005) 2159-2168
36. Lawrence H.J., Rozenfeld S., Cruz C., et al. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13 (1999) 1993-1999
37. Kroon E., Krosl J., Thorsteinsdottir U., Baban S., Buchberg A.M., and Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17 (1998) 3714-3725
38. Lessard J., and Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423 (2003) 255-260
39. Warner J.K., Wang J.C., Takenaka K., et al. Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells. Leukemia 19 (2005) 1794-1805